Skip to main menu
|
Skip to main content
Apotex Worldwide
Drop Down Menu : ww_country
Select Country
Canada
India
Latin America
New Zealand
Saudi Arabia
United States
Search
When autocomplete results are available use up and down arrows to review and enter to select.
Home
About Us
About Apotex
Our Leadership
Corporate Responsibility
Press Center
APOblog
Products
Healthcare Professionals
R & D
Business Opportunities
International Business Development Opportunities
Co-Development
Out-Licensing in EMEA
Submit Your Opportunity
API
API Expertise & Global Presence
Core Competencies
IP & R&D Support
Regulatory & Compliance
Quality
Manufacturing Facilities
API Brantford - Canada
Signa de CV, Mexico
APIPL - India
Product List
Careers
Contact Us
Apotex Worldwide
Adverse Reaction Contact Information
Home
About Us
APOblog
About Us
About Apotex
Our Leadership
Corporate Responsibility
Press Center
APOblog
Categories
Updates
(3)
Innovation
(5)
Leadership
(2)
Learning and Development
(3)
Our Culture
(16)
Our Giving
(4)
Our Industry
(4)
Our People
(34)
Women in Leadership
(1)
APOblog
Our People
Aug 31, 2021
Q&A with Lorna Harris
Our People
Jun 8, 2021
Q&A with Al Todd
Our Giving
Apr 8, 2021
What is the Apotex Giving Philosophy?
Our People
Apr 5, 2021
Q&A with Emilija Fredro-Kumbaradzi
Our People
Mar 5, 2021
Q&A with Johnny Cheong
Our Culture
Feb 23, 2021
How We’re Changing Our Meeting Culture
Our People
Feb 12, 2021
Meet Two of Our APOcampus Students
Our People
Jan 29, 2021
Q&A with Prasad Panzade
Our Culture
Jan 21, 2021
Women in Leadership: Building an Inclusive Culture
Updates
Dec 17, 2020
Our Most-Read Stories Of The Year…
Innovation
Dec 8, 2020
COVID-19 Brings into Sharp Focus the Value of a Strong Canadian Generic Pharmaceutical Industry
Our People
Dec 2, 2020
Q&A with Brad Fewkes
Innovation
Nov 16, 2020
Biosimilars: Increasing Patient Access and Sustainable Healthcare
Our People
Nov 9, 2020
Q&A with Catherine Chao
1
2
3
4
5
